Skip to main content
Journal cover image

Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women.

Publication ,  Journal Article
Maldonado, SS; Cedars, MI; Yates, KP; Wilson, LA; Gill, R; Terrault, NA; Suzuki, A; Sarkar, MA
Published in: Clin Gastroenterol Hepatol
February 2024

BACKGROUND & AIMS: Antimüllerian hormone (AMH) is a marker of ovarian reserve with emerging data linking lower levels to some metabolic and inflammatory diseases in women. Whether AMH levels influence nonalcoholic fatty liver disease (NAFLD) is unknown. METHODS: Leveraging the NASH Clinical Research Network we determined the association of AMH levels within 6 months of liver biopsy with presence and severity of histologic measures of NAFLD in premenopausal women. Outcomes included presence of nonalcoholic steatohepatitis (NASH), presence and severity of fibrosis, and NAFLD Activity Score and its components. Logistic and ordinal logistic regression models were adjusted for age, race/ethnicity, homeostatic model assessment for insulin resistance, body mass index, dyslipidemia, polycystic ovary syndrome, estrogen-progestin use, and menstrual cyclicity. RESULTS: Median cohort age was 35 years; 73% were white and 24% Hispanic. Thirty-three percent had diabetes, 81% had obesity, and 95% had dyslipidemia. On biopsy 71% had NASH, 68% had any fibrosis, and 15% had advanced fibrosis. On adjusted analysis (n = 205), higher AMH quartiles were inversely associated with NAFLD histology including prevalent NASH (adjusted odds ratio [AOR], 0.64; 95% confidence interval [CI], 0.41-1.00), NAFLD Activity Score ≥5 (AOR, 0.52; 95% CI, 0.35-0.77), Mallory hyaline (AOR, 0.54; 95% CI, 0.35-0.82), and higher fibrosis stage (AOR, 0.70; 95% CI, 0.51-0.98). The protective effects of AMH were more pronounced among women without polycystic ovary syndrome (n = 164), including lower odds of NASH (AOR, 0.53; 95% CI, 0.32-0.90) and any NASH fibrosis (AOR, 0.54; 95% CI, 0.32-0.93). CONCLUSIONS: AMH may reflect a unique biomarker of NASH in premenopausal women and findings suggest a novel link between reproductive aging and histologic severity of NAFLD in women.

Duke Scholars

Published In

Clin Gastroenterol Hepatol

DOI

EISSN

1542-7714

Publication Date

February 2024

Volume

22

Issue

2

Start / End Page

339 / 346.e5

Location

United States

Related Subject Headings

  • Polycystic Ovary Syndrome
  • Ovarian Reserve
  • Non-alcoholic Fatty Liver Disease
  • Liver Cirrhosis
  • Liver
  • Humans
  • Gastroenterology & Hepatology
  • Female
  • Dyslipidemias
  • Biopsy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Maldonado, S. S., Cedars, M. I., Yates, K. P., Wilson, L. A., Gill, R., Terrault, N. A., … Sarkar, M. A. (2024). Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women. Clin Gastroenterol Hepatol, 22(2), 339-346.e5. https://doi.org/10.1016/j.cgh.2023.08.020
Maldonado, Stephanie S., Marcelle I. Cedars, Katherine P. Yates, Laura A. Wilson, Ryan Gill, Norah A. Terrault, Ayako Suzuki, and Monika A. Sarkar. “Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women.Clin Gastroenterol Hepatol 22, no. 2 (February 2024): 339-346.e5. https://doi.org/10.1016/j.cgh.2023.08.020.
Maldonado SS, Cedars MI, Yates KP, Wilson LA, Gill R, Terrault NA, et al. Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women. Clin Gastroenterol Hepatol. 2024 Feb;22(2):339-346.e5.
Maldonado, Stephanie S., et al. “Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women.Clin Gastroenterol Hepatol, vol. 22, no. 2, Feb. 2024, pp. 339-346.e5. Pubmed, doi:10.1016/j.cgh.2023.08.020.
Maldonado SS, Cedars MI, Yates KP, Wilson LA, Gill R, Terrault NA, Suzuki A, Sarkar MA. Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women. Clin Gastroenterol Hepatol. 2024 Feb;22(2):339-346.e5.
Journal cover image

Published In

Clin Gastroenterol Hepatol

DOI

EISSN

1542-7714

Publication Date

February 2024

Volume

22

Issue

2

Start / End Page

339 / 346.e5

Location

United States

Related Subject Headings

  • Polycystic Ovary Syndrome
  • Ovarian Reserve
  • Non-alcoholic Fatty Liver Disease
  • Liver Cirrhosis
  • Liver
  • Humans
  • Gastroenterology & Hepatology
  • Female
  • Dyslipidemias
  • Biopsy